Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD. That's the hope of a new line of research underway at the University of California, Davis.

Please provide your email address to receive an email when new articles are posted on . Text messages addressing barriers to preventer inhaler use came from general practitioner practices. Patients ...

"Chiesi drops COPD and asthma asset after Phase III miss" was originally created and published by Clinical Trials Arena, a ...

How can inhalers contribute to greenhouse gas (GHG) emissions? This is what a recent study published in JAMA hopes to address as a team of scientists investigated the environmental impacts of inhalers ...

During an asthma check-up at Brigham and Women's Hospital in Boston, Joel Rubinstein gets a surprising pitch — for the planet, as well as his health. His pulmonologist, Dr. Miguel Divo, explains that ...

The gold standard for teaching inhaler technique is an intervention called TTG, which combines assessment and education through rounds of demonstration and patient teach-back. Essentially, the patient ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study — the largest to date quantifying inhaler-related ...

Drugmaker AstraZeneca said it intends to cap out-of-pocket prices of four medicines used to treat asthma and chronic obstructive pulmonary disease (COPD) to $35 per month for many patients. Starting ...

Early fall is when asthma flare-ups peak in the US, and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke - all triggers for ...